Skip to content

Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy

Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06473103
Enrollment
52
Registered
2024-06-25
Start date
2024-10-29
Completion date
2026-04-30
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma

Brief summary

The goal of this clinical trial is to compare the use of two photon fluorescence microscopy for detecting residual basal cell carcinoma during standard local excision.

Detailed description

This study is an study of skin cancer that will evaluate the feasibility of two photon fluorescence microscopy (TPFM) to evaluate surgical margins followed by standard of care permanent sections for final margin confirmation. To protect patients, following TPFM imaging, patients will receive standard of care evaluation on permanent sections, thus all patients will receive standard of care confirmation following experimental imaging. Individual excisions from consenting patients will be selected, fluorescently labeled and the distance to inked margins measured with TPFM. Following imaging, specimens will be submitted for paraffin processing as per normal procedure and the resulting slides scanned. The distance to the inked margin will be measured on the permanent sections and compared to TPFM to determine accuracy.

Interventions

DEVICETwo photon fluorescence microscopy imaging

Excised tissues will be imaged with two photon fluorescence microscopy prior to submission for histological processing.

Sponsors

Rochester Dermatologic Surgery
CollaboratorOTHER
University of Rochester
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Undergoing treatment for basal cell carcinoma without Mohs surgery at the performance site * Able to read and understand consent form

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Quantitative agreement between clear margin distance on TPFM and conventional paraffin embedded histologyUpon receipt of postoperative pathology slides, typically 2-4 weeks post surgeryThe distance from the furthest extent of the tumor to the nearest surgical margin will be measured on both TPFM and conventional paraffin histology and the numerical difference calculated.

Secondary

MeasureTime frameDescription
Overall agreement on margin statusUpon receipt of postoperative pathology slides, typically 2-4 weeks post surgeryThe status of margins (positive/negative) will be compared

Countries

United States

Contacts

Primary ContactMichael Giacomelli, Ph.D.
mgiacome@ur.rochester.edu5852766260

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026